Background: Several studies have demonstrated that age, comorbidities, and abnormalities in different clinical biomarkers can be important in understanding disease severity. Although clinical features of COVID-19 have been widely described, the assessment of alterations of the most common biochemical markers that are reported in patients with COVID-19 still has not been well established especially in the elderly population.Methods: Here, we report the blood biochemical indicators of fifty-eight elderly patients (Age: 61.03±7.29) with COVID-19. Throatswab upper respiratory samples were obtained from patients, and real-time PCR was used to confirm SARS-CoV-2 infection. Then, biochemical parameters were categorized and analyzed according to these clinical characteristics. This retrospective study involved investigating the medical e-records of COVID-19 positive patients who presented to a COVID-19 centre in Qatar in July 2020.Results: Of the 58 investigated patients, 58.62% were male and 41.38% were Female. 5.17% of the patients had low viral load (i.e., cycle threshold (Ct) ≥ 30) and 94.83% had a high viral load (ie; Ct < 30). Hypocalcemia and uremia affected 12.07% and hypochloremia affected 17.23% of the patients. 27.59% suffered from hyponatremia, 27.59 % had low creatinine, 24.14% had high levels of Alanine transaminase (ALT), 25.86% had high levels of aspartate transferase (AST), and 65.52% had a high level of C-reactive protein (CRP).
Conclusion:Elderly COVID-19 positive patients have been shown to have a disturbance in their biochemical parameters. Indeed, various biochemical parameters measured at baseline can provide useful prognostic information among COVID-19-affected patients. It can also help in the early identification of patients who merit aggressive institutional care, thereby potentially mitigating mortality.